Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe
2007
Study of hepatitis C virus entry in genetically humanized mice
2012 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables
2002
Nutraceuticals: Facts and fiction
2007 Standout
The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics
2008 Standout
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450
2004
Cytochrome P450: taming a wild type enzyme
2011 StandoutNobel
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Biotransformation of Two β-Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring
2013
Lonafarnib: First Approval
2021
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Hallmarks of aging: An expanding universe
2023 Standout
Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues
2005
VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
2004
Effects of endocrine disrupting chemicals on the expression of CYP19 genes in zebrafish (Danio rerio) juveniles
2004
A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells
2008
Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events
2015
Posaconazole: clinical pharmacology and potential for management of fungal infections
2005
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Dietary phenolics: chemistry, bioavailability and effects on health
2009 Standout
A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma
2006
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
2007
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
2002 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants
2006
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
2004 Standout
Plasma Kinetics and Urinary Excretion of the Flavanones Naringenin and Hesperetin in Humans after Ingestion of Orange Juice and Grapefruit Juice
2001
Pomegranate Juice Does Not Impair Clearance of Oral or Intravenous Midazolam, a Probe for Cytochrome P450‐3A Activity: Comparison With Grapefruit Juice
2007
Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships
2002 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Engineering and assaying of cytochrome P450 biocatalysts
2008
Drug Interactions with Grapefruit Juice
1998
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
2005 Standout
Multitargeted therapy of cancer by silymarin
2008 Standout
Zygomycosis (mucormycosis): emerging clinical importance and new treatments
2004
Primary brain tumours in adults
2012 Standout
DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling
2003
Ezetimibe
2005
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
2010
Non‐natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins
2014 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects
2006
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
2006
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Inhibition and induction of human cytochrome P450 (CYP) enzymes
1998
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
2006 Standout
One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?
2006 Standout
Inhibition of P-Glycoprotein Transport Function by Grapefruit Juice Psoralen
2001
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain
2007
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
DNA Adduct Formation by the Anticancer Drug Ellipticine and Its Hydroxy Derivatives in Human Breast Adenocarcinoma MCF-7 Cells
2004
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health
2011 Standout
The Organocatalytic Approach to Enantiopure 2H‐ and 3H‐Pyrroles: Inhibitors of the Hedgehog Signaling Pathway
2016 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Posaconazole: A Next-Generation Triazole Antifungal
2007
Pyrrolizidine Alkaloids—Genotoxicity, Metabolism Enzymes, Metabolic Activation, and Mechanisms
2004 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Phenolic compounds and related enzymes as determinants of quality in fruits and vegetables
2001 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
2012
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
2012
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Biomedical Importance of Indoles
2013 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Pharmacogenetics of Gilbert‘s Syndrome
2008
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
1998
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Works of Anima Ghosal being referenced
IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)
2004
Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor
2010
IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA)
2004
Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist
2010
IDENTIFICATION OF HUMAN LIVER CYTOCHROME P450 ENZYMES RESPONSIBLE FOR THE METABOLISM OF LONAFARNIB (SARASAR)
2006
Identification of Human Liver Cytochrome P450 Enzymes Involved in Biotransformation of Vicriviroc, a CCR5 Receptor Antagonist
2007
Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes
2003
Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of δ-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats
1999
Induction of the Male-Specific Cytochrome P450 3A2 in Female Rats by Phenytoin
1996
Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum
2003
Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
1996